While this is turning out to be one of the worst weeks for Canadian stocks in decades, this toilet paper stock has, in fact, surged approximately 15%. The $1.2 billion Cascades (TSX:CAS) will likely be the beneficiary as coronavirus fears continue.
Many top TSX heavyweight stocks have tumbled to multi-year low levels this week. Interestingly, Cascades stock has continued to see upward momentum recently. The stock is close to its 52-week high at the moment. It is up almost 60% in the last 12 months alone.
Toilet paper is the new currency
Kingsey Falls-based Cascades produces and sells tissue and packaging products composed mainly of recycled fiber. It is the fourth-largest toilet paper producer in North America.
As people are going crazy over toilet paper and hoarding it amid the virus fears, it could positively impact the company’s topline. Notably, Cascades generated more than 30% of its total revenues from toilet paper in 2019.
The company has been consistently increasing its revenues and profits in the last few years. In 2019, it reported a net income of $96 million, an increase of more than 20% YoY. Its 2018 bottom line growth was also substantial against 2017. Analysts expect fair earnings growth in 2020.
Diversified paper and packaging business
This indicates that the company is doing great financially in the regular course of business. Now that demand for toilet paper has skyrocketed, Cascades may now enjoy the windfall gains. Interestingly, even when the virus epidemic will soothe and demand for toilet paper will normalize, the company will likely be well placed in the long term.
Cascades generates a large chunk of its sales from corrugated products in North America and coated box boards in Europe. While the whole supply chain has broken globally and these industrial packaging segments could suffer, its improved toilet paper sales could compensate for the lost opportunities amid the pandemic.
In terms of valuation, Cascades stock is currently trading at a forward price-to-earnings valuation of 12 times. This appears to be a fairly cheap and indicates that the stock may have room to gain going forward. Also, its five-year historical valuation average comes around similar levels.
The stock is trading at a forward PE ratio of 13 times, which looks a tad expensive compared to Cascades, even after the selloff. KP Tissue stock has fallen 5% in the last 12 months, significantly underperforming CAS stock.
Cascades stock is currently trading at a dividend yield of 2.7%. In 2020, the company is expected to pay a dividend of $0.32 per share. In comparison, KP Tissue yields a much higher 8.6%.
Cascades stock looks an attractive investment mainly due to its fair yield and a discounted valuation at the moment.
Also, it uses renewable energy sources and recycles products in manufacturing, making it among a very few socially responsible companies—a must for ESG (environmental, social, and governance) investors.
Renowned Canadian investor Iain Butler just named 10 stocks for Canadians to buy TODAY. So if you’re tired of reading about other people getting rich in the stock market, this might be a good day for you.
Because Motley Fool Canada is offering a full 65% off the list price of their top stock-picking service, plus a complete membership fee back guarantee on what you pay for the service. Simply click here to discover how you can take advantage of this.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned.